NOV 13, 2017 03:24 PM PST

Technique Makes More Ovarian Cancer Glow

WRITTEN BY: Xuan Pham

Image credit: Pixabay.com

Surgical removal of the tumor remains one of the most effective lines of defense for cancer patients. However, among other drawbacks, surgery treatment is limited by how much of the tumor can be seen or felt by the surgeon. To help doctors be more thorough in the removal of ovarian tumors, scientists  devised an imaging technique that penetrates deeper into the tissue, improving visualization overall.
 
Ovarian cancers have one of the highest mortality rates, ranking fifth in cancer deaths among women. The American Cancer Society estimated over 21,000 women in the US received a new diagnosis of ovarian cancer in 2015. Of these newly diagnosed women, about two thirds will succumb to the disease. The outcome for ovarian cancer is inherently tied to successful and complete removal of the tumor. But the removal has room for improvement, as senior study author Alexander L. Vahrmeijer explains: "Surgery is the most important treatment for ovarian cancer, and surgeons mainly have to rely on their naked eyes to identify tumor tissue, which is not optimal."

To better visualize the tumor, the research team used a new fluorescent agent called OTL38. This agent binds to a protein that’s highly expressed in ovarian cancer, marking this tissue for removal. In combination, the team devised a new imaging system known as "near infrared (NIR) fluorescence imaging.” Along with the tumor-specific marker, the NIR system allows light to penetrate deeper into tissues, in the order of centimeters.


"This allowed resection of additional tumor lesions that were not visible to the surgeons' naked eyes," said Vahrmeijer. "Although more research is needed, this is hopefully the first step toward improving the surgical outcome of cancer patients."

In clinical trials, the team tested the technique in 12 patients with ovarian cancer. They found that with the help of OTL38 and NIR, surgeons were able to remove, on average, 29 percent more malignant tissues than they could have with standard techniques.

The team plans to test this technique further in a larger study population to assess its sensitivity and specificity. "A limitation of this study is that we cannot say yet what the impact of our findings is on cure or survival of the patients. It is reasonably plausible to assume that if more cancer is removed the survival will be better. However, long-term follow-up studies need to be performed in large patient groups to prove such effects,” Vahrmeijer noted.


Additional source: American Association for Cancer Research

About the Author
  • I am a human geneticist, passionate about telling stories to make science more engaging and approachable. Find more of my writing at the Hopkins BioMedical Odyssey blog and at TheGeneTwist.com.
You May Also Like
JUN 05, 2018
Cell & Molecular Biology
JUN 05, 2018
Mechanism of Aspirin's Anti-Colon Cancer Effects Revealed
For some people, aspirin can help prevent colon cancer; now researchers have learned more about how that happens....
JUN 27, 2018
Immunology
JUN 27, 2018
Immune Cells Responsible for Chemo-induced Diarrhea
While studying specific immune cells in the context of chronic itching in the skin, two Washington University School of Medicine scientists discovered that...
JUL 31, 2018
Cancer
JUL 31, 2018
Protein Regulation of DNA Replication in Cancer Cells - A New Early Target for Broad Therapeutics?
DNA replication is a carefully regulated process in each cell of the body. Researchers are looking at the mechanism of DNA replication and associated proteins as a therapy target in cancer...
AUG 14, 2018
Cancer
AUG 14, 2018
New Drug for Refractory Cutaneous T-cell Lymphoma
Mogamulizumab was approved by the FDA this month after a very successful Phase III clinical trial demonstrating its effectiveness in treating patients with challenging CTCL....
AUG 21, 2018
Immunology
AUG 21, 2018
T cells Trapped by Brain Cancer
Brain tumors prevent T cells from escaping the bone marrow by altering levels of the S1P1 protein....
SEP 13, 2018
Cancer
SEP 13, 2018
Breast tumors can stop their own metastasis
According to the American cancer society, metastatic breast cancers or stage 4 breast cancers have 5-years survival rate of 22% which is lower than at early stages. Metastatic breast cancer...
Loading Comments...